Cancer Cell Membrane Camouflaged Mesoporous Silica Nanoparticles Combined with Immune Checkpoint Blockade for Regulating Tumor Microenvironment and Enhancing Antitumor Therapy

PURPOSE: Although anti-programmed cell death protein 1 antibody (aPD1) immunotherapy and chemotherapy has made much progress in the treatment of melanoma, the efficacy still needs to be further improved. METHODS: Cancer treatment has been greatly enhanced by the use of nanotechnology. Cancer cell me...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Peiqi, Qiu, Lihua, Zhou, Shiyong, Li, Lanfang, Qian, Zhengzi, Zhang, Huilai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7966413/
https://www.ncbi.nlm.nih.gov/pubmed/33737808
http://dx.doi.org/10.2147/IJN.S295565

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7966413/
https://www.ncbi.nlm.nih.gov/pubmed/33737808
http://dx.doi.org/10.2147/IJN.S295565

Ejemplares similares